CVRx (CVRX) Cash from Operations Growth (1y) (2021 - 2026)
CVRx (CVRX) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 122.43% |
| 10 | CVRx | 127.01 Mn | 54.70 Mn | 12.88 Mn | 4.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.72% |
| Dec 31, 2025 | -21.85% |
| Sep 30, 2025 | 6.73% |
| Jun 30, 2025 | 19.27% |
| Mar 31, 2025 | -17.17% |
| Dec 31, 2024 | -2.16% |
| Sep 30, 2024 | -28.12% |
| Jun 30, 2024 | 23.25% |
| Mar 31, 2024 | -6.31% |
| Dec 31, 2023 | 27.69% |
| Sep 30, 2023 | 26.78% |
| Jun 30, 2023 | -26.86% |
| Mar 31, 2023 | 3.71% |
| Dec 31, 2022 | -54.54% |
| Sep 30, 2022 | -20.41% |
| Jun 30, 2022 | -56.19% |
| Mar 31, 2022 | -111.27% |
| Dec 31, 2021 | -71.77% |
| Sep 30, 2021 | -78.69% |